Back
Alzamend Neuro Inc ALZN · Insights
Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various prod... Price1.42
Market Cap6.8 M
Float4.7 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro